Advance Sentry Corporation · Viral Genetic Diagnostics
Early detection of viral-related cancers — non-invasive and precise.
Advance Sentry is a Canadian company specialising in viral genetic-based diagnostic technology. Its first product, NP Screen™, is the only FDA-approved non-invasive method for the early detection of nasopharyngeal carcinoma. Interblock is guiding Advance Sentry to the public markets.
Our mission
To safeguard patients’ health through the early detection of viral-related cancers — at the onset of tumour transformation — improving treatment response and outcomes.
NP Screen™
The highest-accuracy early screen for nasopharyngeal carcinoma.
Simple, non-invasive, painless — and the only FDA-approved method of its kind on the market.
Over 99% accuracy
The highest-accuracy early-detection screen for nasopharyngeal carcinoma available today.
Accuracy 02FDA-approved Class II
A cleared Class II medical device — the only FDA-approved direct, ambulatory, non-invasive early-detection method on the market.
Regulatory 03Non-invasive & painless
A simple, direct, ambulatory screen — enabling extremely early detection without discomfort to the patient.
Patient-first 044,000+ clinical trials
Validated across more than 4,000 clinical trials conducted in Canada and Hong Kong.
Evidence 05WHO recognised
Recognised by the World Health Organization for its role in early cancer detection.
Endorsement 06First of a series
NP Screen™ is the first product in Advance Sentry’s viral-genetic diagnostic series.
PipelineDr. Raymond Ng
Led the medical team through the entire R&D process — clinical trial design, planning and regulatory approval. A Fellow in Otolaryngology – Head and Neck Surgery (Royal College of Physicians and Surgeons of Canada, 1993) with over 30 years of experience, involved in the original EBV DNA research and developer of the trans-oral brushing biopsy method for the nasopharynx.
Dr. John Phillips
Oversees product design, development and quality assurance across all regulatory submissions. A qualified plastic and craniofacial surgeon (MD 1980; Fellow, Royal College, 1985) with 30+ years of surgical experience, an extensive publication record and deep expertise launching medical devices in North America.
Their website
Explore NP Screen™ and the full Advance Sentry story.
Part of the Interblock portfolio